Biological Information
Background Information:
Cathepsin B, L and H are lysosomal enzymes that belong to the papain superfamily of cysteine proteinases. They are thought to be involved in tumor invasion and metastasis. In addition, high levels of Cathepsin B have been found in the synovial fluid of rheumatoid arthritis patients which may degrade collagen. Inhibition of Cathepsin B may reduce inflammation, tumor growth and angiogenesis.
Family:
Protease
Sub Family:
Papain
Class:
Cysteine Peptidase
Protein Name:
Cathepsin B
Uniprot Number:
P07858
Gene Name:
CTSB
Gene ID:
1508
Accession Number:
NM_147780
Organism:
Human
Construct Details:
Endogenous
Assay Information
Assay Type:
Biochemical
Assay Sub Type:
Enzymatic
Functional Mode:
Antagonist
Detection Method:
Spectrofluorimetry
Measured Response:
Fluorescence
Testing Information
Procedure Summary:
Human liver Cathepsin B is used. Test compound and/or vehicle is incubated with 3.94 mU/ml enzyme‡ in modified acetate buffer pH 5.5 for 15 minutes at 25°C. The reaction is initiated by addition of and 20 μM Boc-Leu-Arg-Arg-AMC for another 30 minute incubation period. Determination of the amount of AMC formed is read spectrofluorimetrically at 360 nm/465 nm. Compounds are screened at 10 μM.
Substrate:
20 µM Boc-Leu-Arg-Arg-AMC
Incubation:
30 min at 25°C
Control Inhibitor:
CA-074
Criteria For Significance:
≥ 50% of max stimulation or inhibition
Test Concentration / Dose:
Suggested concentration for initial testing is 10 uM
Test Sample Requirements:
Minimum for 1) Screen: 25 μl of 10 mM stock -OR- 1 mg (pre-weighed). 2) Dose Response: 60 μl of 10 mM stock -OR- 1 mg (pre-weighed).
Minimum Order Quantity:
2
Turnaround Time
Standard:
15 Business Days
Reference Compound Data
Clinical Relevance
Therapeutic Area:
Inflammation/Allergy
Additional Information
Brand:
LeadHunter
Testing Location:
Taiwan - Taipei
RELATED SOLUTIONS